These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 26222329

  • 21. Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Lewis SJ, Kays MB, Mueller BA.
    J Clin Pharmacol; 2016 Oct; 56(10):1277-87. PubMed ID: 26919659
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients: a pilot study.
    Langan KM, Jacob J, Li J, Nation RL, Bellomo R, Howden B, Johnson PD.
    Crit Care Resusc; 2014 Sep; 16(3):190-6. PubMed ID: 25161021
    [Abstract] [Full Text] [Related]

  • 26. Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy.
    Thy M, Urien S, Bouazza N, Foissac F, Gana I, Bille E, Béranger A, Toubiana J, Berthaud R, Lesage F, Renolleau S, Tréluyer JM, Benaboud S, Oualha M.
    Clin Pharmacokinet; 2022 Nov; 61(11):1609-1621. PubMed ID: 36251162
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
    Ulldemolins M, Vaquer S, Llauradó-Serra M, Pontes C, Calvo G, Soy D, Martín-Loeches I.
    Crit Care; 2014 Jun 23; 18(3):227. PubMed ID: 25042938
    [Abstract] [Full Text] [Related]

  • 29. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.
    Chung EK, Cheatham SC, Fleming MR, Healy DP, Kays MB.
    J Clin Pharmacol; 2017 Mar 23; 57(3):356-368. PubMed ID: 27530916
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ, Jennings AC, Thomson AH, Creed G, Beale RJ, McLuckie A.
    Crit Care Med; 2000 Mar 23; 28(3):632-7. PubMed ID: 10752806
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
    Thalhammer F, Hörl WH.
    Clin Pharmacokinet; 2000 Oct 23; 39(4):271-9. PubMed ID: 11069213
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis.
    Kawano S, Matsumoto K, Hara R, Kuroda Y, Ikawa K, Morikawa N, Horino T, Hori S, Kizu J.
    J Infect Chemother; 2015 Jun 23; 21(6):476-8. PubMed ID: 25869915
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy.
    Langgartner J, Vasold A, Glück T, Reng M, Kees F.
    Intensive Care Med; 2008 Jun 23; 34(6):1091-6. PubMed ID: 18297267
    [Abstract] [Full Text] [Related]

  • 38. Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: dosing considerations.
    Kondo N, Ikawa K, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Ohge H, Morikawa N, Sueda T.
    Pancreatology; 2014 Jun 23; 14(2):95-9. PubMed ID: 24650961
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.
    Awissi DK, Beauchamp A, Hébert E, Lavigne V, Munoz DL, Lebrun G, Savoie M, Fagnan M, Amyot J, Tétreault N, Robitaille R, Varin F, Lavallée C, Pichette V, Leblanc M.
    Pharmacotherapy; 2015 Jun 23; 35(6):600-7. PubMed ID: 26095008
    [Abstract] [Full Text] [Related]

  • 40. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R, RENAL Replacement Therapy Study Investigators.
    Crit Care Med; 2012 May 23; 40(5):1523-8. PubMed ID: 22511133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.